Repligen (RGEN) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Powered by 
Analysis
Repligen (RGEN) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.18% |
| Mar 31, 2026 | -74.98% |
| Dec 31, 2025 | 124.41% |
| Sep 30, 2025 | 0.30% |
| Jun 30, 2025 | 154.99% |
| Mar 31, 2025 | 105.17% |
| Dec 31, 2024 | -17,134.40% |
| Sep 30, 2024 | -111.45% |
| Jun 30, 2024 | 73.38% |
| Mar 31, 2024 | -60.95% |
| Dec 31, 2023 | -50.14% |
| Sep 30, 2023 | -14.47% |
| Jun 30, 2023 | -31.37% |
| Mar 31, 2023 | -40.84% |
| Dec 31, 2022 | 20.60% |
| Sep 30, 2022 | -18.96% |
| Jun 30, 2022 | 5.30% |
| Mar 31, 2022 | 62.66% |
| Dec 31, 2021 | -13.10% |
| Sep 30, 2021 | -7.55% |